Michael Zasloff
Director/Board Member chez AMPHASTAR PHARMACEUTICALS, INC.
Fortune : 936 425 $ au 31/03/2024
Profil
Michael A.
Zasloff was the founder of Genaera Corp.
(founded in 1992) where he held the title of Vice Chairman & Executive Vice President in 2001.
He is also the founder of Formula XO, Inc. (founded in 2013) where he currently holds the title of Chief Scientific Officer & Director.
Additionally, he is the founder of Enterin, Inc. (founded in 2016) where he currently holds the title of Director & Chief Scientific Officer.
Dr. Zasloff's current job(s) include being an Independent Director at Amphastar Pharmaceuticals, Inc. since 2005 (current) and a Professor-Surgery & Pediatrics at Georgetown University School of Medicine since 2002 (current).
His former job(s) include being a Vice President & Senior Analyst at Ferris, Baker Watts, Inc. from 2004 to 2007, Chief-Human Genetics Branch at National Institutes of Health from 1982 to 1988, Professor at Perelman School of Medicine from 1988 to 1992, Professor at the University of Pennsylvania Medical Center from 1988 to 1992, and Chief-Human Genetics & Molecular Biology Division at The Children's Hospital of Philadelphia from 1988 to 1992.
Dr. Zasloff's education history includes an undergraduate degree from Columbia College (California) and a doctorate degree from New York University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/03/2024 | 21 326 ( 0,04% ) | 936 425 $ | 31/03/2024 |
Postes actifs de Michael Zasloff
| Sociétés | Poste | Début |
|---|---|---|
| AMPHASTAR PHARMACEUTICALS, INC. | Director/Board Member | 01/10/2005 |
| Georgetown University School of Medicine | Corporate Officer/Principal | 01/01/2002 |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Founder | 01/01/2016 |
Formula XO, Inc.
 Formula XO, Inc. Household/Personal CareConsumer Non-Durables Formula XO, Inc. manufactures beauty solutions. It develops, manufactures and distributes the illumai Biome Care System for the hair– the only hair system on the market made to protect, nurture and maintain the biome of the hair, skin and scalp. The company was founded by Wayne Willis, Mario Russo and Michael Zasloff in 2013 and is headquartered in Sterling, VA. | Founder | 01/01/2013 |
Anciens postes connus de Michael Zasloff
| Sociétés | Poste | Fin |
|---|---|---|
Ferris, Baker Watts, Inc.
 Ferris, Baker Watts, Inc. Investment Banks/BrokersFinance Ferris, Baker Watts, Inc. is a full-service investment banking firm with expertise in mergers and acquisitions, debt and equity underwritings, and other investment banking functions. They are headquartered in Washington, DC with additional offices in Baltimore, Richmond and San Francisco. They are a member of the NYSE and SIPC, and are wholly-owned by their employees. They serve clients throughout the mid-Atlantic region | Analyst-Equity | 01/01/2007 |
Genaera Corp.
 Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Founder | 01/01/2001 |
| Perelman School of Medicine | Corporate Officer/Principal | 01/01/1992 |
The Children's Hospital of Philadelphia
 The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/01/1992 |
| University of Pennsylvania Medical Center | Corporate Officer/Principal | 01/01/1992 |
Formation de Michael Zasloff
| Columbia College (California) | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMPHASTAR PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
Formula XO, Inc.
Formula XO, Inc. Household/Personal CareConsumer Non-Durables Formula XO, Inc. manufactures beauty solutions. It develops, manufactures and distributes the illumai Biome Care System for the hair– the only hair system on the market made to protect, nurture and maintain the biome of the hair, skin and scalp. The company was founded by Wayne Willis, Mario Russo and Michael Zasloff in 2013 and is headquartered in Sterling, VA. | Consumer Non-Durables |
Ferris, Baker Watts, Inc.
Ferris, Baker Watts, Inc. Investment Banks/BrokersFinance Ferris, Baker Watts, Inc. is a full-service investment banking firm with expertise in mergers and acquisitions, debt and equity underwritings, and other investment banking functions. They are headquartered in Washington, DC with additional offices in Baltimore, Richmond and San Francisco. They are a member of the NYSE and SIPC, and are wholly-owned by their employees. They serve clients throughout the mid-Atlantic region | Finance |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Health Services |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
